Autonomix Medical, Inc. (AMIX)
$3.10-0.32%Close
SELLCRISIS · day 44
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $2M
- Beta
- -1.30
- P/E (TTM)
- -0.07
- Short % float
- 5.10%
- Days to cover
- 1.0
- SI change
- -56.3%
- 1W
- -12.43%
- 1M
- -29.06%
- vs SPY 1W
- -12.85%
- vs SPY 1M
- -31.12%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 3
- VALUE
- 6
- GROWTH
- 43
- GARP
- 0
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-160.6%
REV YoY-
ROE-45.2%
EPS YoY-
ROA-404.7%
GROSS0
OP0
NET0
[VALUATION]
P/E TTM-0.07
P/E FWD-
SECTOR PE20.54
INDUSTRY PE22.84
P/B0.60
P/FCF-
EV/EBITDA0.10
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E-
ALTMAN Z-
CURR RATIO4.85
ND/EBITDA-
BETA-1.30
NET INCOME (TTM) < 0
Company news
FAQ
- What is LOPJLB’s current signal on AMIX?
- LOPJLB’s latest quantitative signal on Autonomix Medical, Inc. (AMIX) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is AMIX in?
- Autonomix Medical, Inc. (AMIX) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Autonomix Medical, Inc. (AMIX) do?
- Autonomix Medical, Inc., a development stage medical device company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. The companyâs technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. It develops technology for patients with pancreatic cancer and addr…